FDA panel expected to make decision on COVID-19 treatment pill

Published November 30, 2021 24 Views

Rumble An FDA panel is meeting to vote on recommending an antiviral pill for COVID-19 treatment produced by Merck.

BREAKING: Rumble to Combine with NASDAQ listed CFVI